Hovione appoints Filipe Gaspar as VP of Research and Development

Hovione has announced the promotion of Filipe Gaspar to VP of R&D, reporting to CEO Guy Villax. Gaspar joined Hovione in 2003 and has held a number of positions at the company, including Director of Particle Design and Director of Drug Product Technologies. Most recently, he served as Senior Director of Particle Engineering Services.

Villax commented, “We are very pleased to have Filipe running our R&D. Filipe brings great science and leadership skills. For the last 10 years Filipe has been the driving force behind our particle engineering, and if we have four new drugs today on the market it is because he and his team made sure we had the right capabilities, know-how and ability to deliver.”

Hovione develops and manufactures APIs, formulations, and devices for inhaled and nasal drug delivery, especially DPIs.

Read the Hovione press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan